• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mostly Higher; Dow Surges 300 Points

    10/28/22 10:27:31 AM ET
    $COHU
    $DAIO
    $DVA
    $EGHT
    Electrical Products
    Industrials
    Electrical Products
    Industrials
    Get the next $COHU alert in real time by email

    U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday.

    Following the market opening Friday, the Dow traded up 1.01% to 32,355.66 while the NASDAQ rose 0.06% to 10,799.69. The S&P 500 also rose, gaining, 0.33% to 3,819.94.

    Also check this: Bitcoin Jumps Above 20,000; Here Are The Top Crypto Movers For Wednesday


    Leading and Lagging Sectors


    Information technology shares climbed 2% on Friday. Leading the sector was strength from 8x8, Inc. (NYSE:EGHT) and Cohu, Inc. (NASDAQ:COHU).


    In trading on Friday, consumer discretionary shares fell by 3.3%.


    Top Headline

     

    Personal spending in the US rose 0.6% month-over-month in September, while personal income increased by 0.4%. The personal consumption expenditure price index in the US increased 0.3% month-over-month in September, the same as in the earlier month.

     

    Equities Trading UP

     

    • Nuvalent, Inc. (NASDAQ:NUVL) shares shot up 69% to $37.12 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive NSCLC.
    • Shares of Data I/O Corporation (NASDAQ:DAIO) got a boost, shooting 23% to $3.7850 after the company reported better-than-expected Q3 results.
    • Provident Acquisition Corp. (NASDAQ:PAQC) shares were also up, gaining 25% to $10.40. Perfect Corp. and Provident Acquisition Corp. recently announced approval of business combination by Provident's shareholders.

     

    Equities Trading DOWN

    • Selina Hospitality PLC (NASDAQ:SLNA) shares tumbled 26% to $29.78.
    • Shares of DaVita Inc. (NYSE:DVA) were down 25% to $72.62 after the company reported worse-than-expected Q3 EPS and sales results and lowered FY22 adjusted EPS guidance below estimates.
    • Edwards Lifesciences Corporation (NYSE:EW) was down, falling 19% to $70.31 after the company reported worse-than-expected Q3 results. The company also lowered its FY22 EPS guidance below analyst estimates.


    Also check out: Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday


    Commodities

    In commodity news, oil traded down 1% to $88.22 while gold traded down 1.1% at $1,647.70.


    Silver traded down 1.4% to $19.22 on Friday while copper fell 2.5% to $3.4320.


    Euro zone


    European shares were mostly lower today. The eurozone’s STOXX 600 slipped 0.2%, London’s FTSE 100 fell 0.5% while Spain’s IBEX 35 Index fell 0.6%. The German DAX fell 0.1%, French CAC 40 rose 0.2% and Italy’s FTSE MIB Index fell 0.5%.

    German economy expanded by 0.3% on quarter during the three months to September, versus a 0.1% growth in the prior period. Spanish consumer price inflation declined to 7.3% year-over-year in October from 8.9% in the previous month, while the country’s economy expanded by 0.2% on quarter during the three months to September. The French economy grew 0.2% on quarter in the third quarter.


    Economics

     

    • Personal spending in the US rose 0.6% month-over-month in September, while personal income increased by 0.4%. The personal consumption expenditure price index in the US increased 0.3% month-over-month in September, the same as in the earlier month.
    • Compensation costs for civilian workers climbed 1.2% on quarter in the third quarter, versus a 1.3% increase in the prior period.
    • The University of Michigan consumer sentiment was revised higher to 59.9 in October versus a preliminary level of 59.8.
    • Pending home sales in the US dipped by 10.2% from a month ago in September.
    • The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.


    Check out this: Market Volatility Increases As US Stocks End Mixed


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 99,281,950 cases with around 1,094,590 deaths. India confirmed a total of at least 44,649,080 cases and 528,990 deaths, while France reported over 36,744,650 COVID-19 cases with 156,770 deaths. In total, there were at least 634,727,460 cases of COVID-19 worldwide with more than 6,589,740 deaths.

    Get the next $COHU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $COHU
    $DAIO
    $DVA
    $EGHT

    CompanyDatePrice TargetRatingAnalyst
    Edwards Lifesciences Corporation
    $EW
    4/1/2026$92.00Peer Perform → Outperform
    Wolfe Research
    Nuvalent Inc.
    $NUVL
    3/30/2026$116.00Overweight
    Wells Fargo
    Cohu Inc.
    $COHU
    3/16/2026$35.00Outperform
    Evercore ISI
    Data I/O Corporation
    $DAIO
    2/2/2026$5.00Buy
    Ladenburg Thalmann
    Edwards Lifesciences Corporation
    $EW
    1/9/2026$97.00Hold → Buy
    TD Cowen
    Edwards Lifesciences Corporation
    $EW
    12/18/2025$100.00Neutral → Overweight
    Analyst
    Nuvalent Inc.
    $NUVL
    11/24/2025Buy
    Truist
    Nuvalent Inc.
    $NUVL
    11/12/2025$126.00Buy
    Canaccord Genuity
    More analyst ratings

    $COHU
    $DAIO
    $DVA
    $EGHT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edwards Lifesciences Reports First Quarter Results

    Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7% Q1 TAVR sales grew 14.4% to $1.20 billion1; constant currency2 sales grew 11.0% Q1 TMTT sales of $173 million1,3, driven by repair and replacement therapies Q1 EPS of $0.661; adjusted2 EPS of $0.781 Raising FY 2026 constant currency2 sales growth guidance to 9% to 11% from 8% to 10% Raising FY 2026 adjusted2 EPS guidance midpoint; new range of $2.95 to $3.05 from $2.90 to $3.05 Renewed clinical focus on proactive disease management with differentiated SAPIEN TAVR Compl

    4/23/26 4:15:00 PM ET
    $EW
    Industrial Specialties
    Health Care

    Nuvalent to Present Pivotal Data from ALKOVE-1 Trial of Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC at the 2026 American Society of Clinical Oncology Annual Meeting

    Company to also present preliminary data for zidesamtinib in advanced ROS1-positive solid tumors outside of NSCLC from the global ARROS-1 trial CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that pivotal data for neladalkib, an investigational ALK-selective inhibitor, in TKI pre-treated patients with advanced ALK-positive non-small cell lung cancer (NSCLC) from the global ALKOVE-1 Phase 1/2 clinical trial, in addition to preliminary data for TKI-naïve patients, will be presented during an oral presentation

    4/21/26 10:32:00 AM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Synthflow AI and 8x8 Enter Strategic Partnership to Deliver Next-Generation Agentic AI

    Synthflow AI, an enterprise AI agent platform that automates customer conversations, has formed a strategic partnership with 8x8, Inc. (NASDAQ:EGHT), a leading global business communications platform provider, to bring Synthflow next-generation AI agents to enterprise contact centers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421904109/en/Synthflow AI and 8x8 Enter Strategic Partnership to Deliver Next-Generation Agentic AI This collaboration integrates Synthflow into the 8x8 Contact Center, automating self-service while enhancing agent support across AI calls, chat, and digital channels. The new technology helps joint c

    4/21/26 6:00:00 AM ET
    $EGHT
    EDP Services
    Technology

    $COHU
    $DAIO
    $DVA
    $EGHT
    SEC Filings

    View All

    Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Edwards Lifesciences Corp (0001099800) (Filer)

    4/23/26 4:20:22 PM ET
    $EW
    Industrial Specialties
    Health Care

    SEC Form DEFA14A filed by DaVita Inc.

    DEFA14A - DAVITA INC. (0000927066) (Filer)

    4/22/26 4:48:12 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEF 14A filed by DaVita Inc.

    DEF 14A - DAVITA INC. (0000927066) (Filer)

    4/22/26 4:30:45 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $COHU
    $DAIO
    $DVA
    $EGHT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bohrson Christopher

    4 - COHU INC (0000021535) (Issuer)

    4/17/26 1:17:58 PM ET
    $COHU
    Electrical Products
    Industrials

    SEC Form 4 filed by Pelish Henry E.

    4 - Nuvalent, Inc. (0001861560) (Issuer)

    4/13/26 4:30:20 PM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Ullem Scott B.

    4 - Edwards Lifesciences Corp (0001099800) (Issuer)

    4/9/26 7:34:07 PM ET
    $EW
    Industrial Specialties
    Health Care

    $COHU
    $DAIO
    $DVA
    $EGHT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Edward J bought $12,300 worth of shares (5,000 units at $2.46), increasing direct ownership by 13% to 42,815 units (SEC Form 4)

    4 - DATA I/O CORP (0000351998) (Issuer)

    5/8/25 3:00:40 PM ET
    $DAIO
    Electrical Products
    Industrials

    Amendment: President Wentworth William O. bought $24,981 worth of shares (10,585 units at $2.36), increasing direct ownership by 43% to 35,085 units (SEC Form 4)

    4/A - DATA I/O CORP (0000351998) (Issuer)

    5/8/25 2:56:48 PM ET
    $DAIO
    Electrical Products
    Industrials

    President Wentworth William O. bought $24,998 worth of shares (10,332 units at $2.42), increasing direct ownership by 29% to 45,417 units (SEC Form 4)

    4 - DATA I/O CORP (0000351998) (Issuer)

    5/7/25 4:33:45 PM ET
    $DAIO
    Electrical Products
    Industrials

    $COHU
    $DAIO
    $DVA
    $EGHT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Edwards Lifesciences upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Edwards Lifesciences from Peer Perform to Outperform and set a new price target of $92.00

    4/1/26 8:10:23 AM ET
    $EW
    Industrial Specialties
    Health Care

    Wells Fargo initiated coverage on Nuvalent with a new price target

    Wells Fargo initiated coverage of Nuvalent with a rating of Overweight and set a new price target of $116.00

    3/30/26 8:25:33 AM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Evercore ISI initiated coverage on Cohu with a new price target

    Evercore ISI initiated coverage of Cohu with a rating of Outperform and set a new price target of $35.00

    3/16/26 8:39:15 AM ET
    $COHU
    Electrical Products
    Industrials

    $COHU
    $DAIO
    $DVA
    $EGHT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nuvalent Inc.

    SC 13G/A - Nuvalent, Inc. (0001861560) (Subject)

    11/14/24 4:50:28 PM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Nuvalent Inc.

    SC 13G/A - Nuvalent, Inc. (0001861560) (Subject)

    11/14/24 4:34:36 PM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 8x8 Inc

    SC 13G/A - 8X8 INC /DE/ (0001023731) (Subject)

    11/14/24 12:23:04 PM ET
    $EGHT
    EDP Services
    Technology

    $COHU
    $DAIO
    $DVA
    $EGHT
    Leadership Updates

    Live Leadership Updates

    View All

    Nuvalent Appoints Ron Squarer to Board of Directors

    CAMBRIDGE, Mass., Dec. 10, 2025 /PRNewswire/ -- Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Ron Squarer to its Board of Directors. "We welcome Ron to our Board of Directors, where his personal dedication to advancing oncology therapeutics, demonstrated success in evolving research and development organizations to fully integrated businesses, and proven global commercial acumen will strengthen and sharpen our pre-launch

    12/10/25 4:01:00 PM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Data I/O Announces Strengthening of Board of Directors

    Edward Smith Appointed Chair of the Board; Steven Waszak Appointed as Independent Director Data I/O Corporation (NASDAQ:DAIO), the leading global provider of data programming and security provisioning solutions for flash, flash-memory based intelligent devices and microcontrollers, announced changes to its Board of Directors intended to strengthen its leadership as the Company focuses on market expansion. Edward Smith, who has served on the Data I/O Board of Directors since 2022, has been appointed Chair of the Board. Steven Waszak has joined the Board of Directors of Data I/O effective December 3, 2025. Sally Washlow will remain on the Board and assumes the position of independent directo

    12/4/25 8:00:00 AM ET
    $AQMS
    $CIEN
    $DAIO
    Metal Fabrications
    Industrials
    Telecommunications Equipment
    Utilities

    Edwards Lifesciences Announces CFO Transition Plan

    Edwards Lifesciences (NYSE:EW) today announced that Scott Ullem, the company's chief financial officer, has decided to transition from his role by midyear 2026. While the company initiates a selection process to appoint a new CFO, this planned transition will enable continuity and a smooth transfer of responsibilities. Following the appointment of a new CFO, Ullem will continue in an advisory role. About Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are insp

    10/30/25 4:15:00 PM ET
    $EW
    Industrial Specialties
    Health Care

    $COHU
    $DAIO
    $DVA
    $EGHT
    Financials

    Live finance-specific insights

    View All

    Edwards Lifesciences Reports First Quarter Results

    Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7% Q1 TAVR sales grew 14.4% to $1.20 billion1; constant currency2 sales grew 11.0% Q1 TMTT sales of $173 million1,3, driven by repair and replacement therapies Q1 EPS of $0.661; adjusted2 EPS of $0.781 Raising FY 2026 constant currency2 sales growth guidance to 9% to 11% from 8% to 10% Raising FY 2026 adjusted2 EPS guidance midpoint; new range of $2.95 to $3.05 from $2.90 to $3.05 Renewed clinical focus on proactive disease management with differentiated SAPIEN TAVR Compl

    4/23/26 4:15:00 PM ET
    $EW
    Industrial Specialties
    Health Care

    DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call

    DENVER, April 20, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 5, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Tuesday, May 5, 2026 Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the co

    4/20/26 2:06:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    8x8, Inc. Schedules Fourth Quarter and Fiscal Year 2026 Earnings Release and Conference Call

    8x8, Inc. (NASDAQ:EGHT), a leading global business communications platform provider, will release financial results for the fourth fiscal quarter and fiscal year ended March 31, 2026 following the close of market on Tuesday, May 19, 2026. The company will host a conference call on the same day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results. Date:     May 19, 2026 Time:     2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) Dial In:     Register to participate in the live call. Upon registering, you will receive dial-in numbers and a unique PIN to join the call. You will also receive an email co

    4/16/26 4:05:00 PM ET
    $EGHT
    EDP Services
    Technology